<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">Xingnaojing consists of musk, turmeric, borneol, gardenia, and other ingredients [
 <xref ref-type="bibr" rid="CR41">41</xref>]. It is commonly used clinically for acute poisoning, viral encephalitis, craniocerebral injury, acute cerebrovascular disease, pulmonary encephalopathy, pneumonia, respiratory failure, and sepsis [
 <xref ref-type="bibr" rid="CR42">42</xref>]. Studies have compared the antipyretic effects of Xingnaojing and Qingkailing on upper respiratory tract infection in adults [
 <xref ref-type="bibr" rid="CR43">43</xref>]. The results showed that the total effective rate in the Xingnaojing treatment group was 91.4%, which was better compared to the Qingkailing control group, with no apparent adverse reactions seen in the treatment group. Xingnaojing can shorten the progression of acute infectious fever, especially the infection caused by viruses. It can significantly reduce the time patients experience fever and effectively shorten the treatment time [
 <xref ref-type="bibr" rid="CR44">44</xref>].
</p>
